Adenosine kinase as a target for therapeutic antisense strategies in epilepsy

Epilepsia

Volumn 52, Issue 3, 2011, Pages 589-601

  Theofilas, Panos ^a   Brar, Sukhmani ^a   Stewart, Kerry Ann ^a   Shen, Hai Ying ^a   Sandau, Ursula S ^a   Poulsen, David ^b   Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

AAV8; Adenoassociated virus; ADK; Gene therapy; RNAi; Seizure

Indexed keywords

ADENOSINE KINASE; COMPLEMENTARY DNA; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOWN REGULATION; DRUG SELECTIVITY; DRUG TARGETING; ELECTROENCEPHALOGRAPHY; EMBRYO; EPILEPSY; GENE EXPRESSION; GENE OVEREXPRESSION; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ADENOSINE KINASE; ANIMALS; ANTICONVULSANTS; ASTROCYTES; DNA, ANTISENSE; DNA, COMPLEMENTARY; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 79952552797     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02947.x     Document Type: Article

References (67)

1. Alisky JM, Davidson BL. (2000) Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases. Hum Gene Ther 11:2315-2329.
2. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TW Jr, Staber PD, Chiorini JA, Davidson BL. (2000) Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11:2669-2673.
3. Araque A, Parpura V, Sanzgiri RP, Haydon PG. (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208-215. (Pubitemid 29202082)
4. Binder DK, Steinhauser C. (2006) Functional changes in astroglial cells in epilepsy. Glia 54:358-368. (Pubitemid 44422938)
5. Boison D. (2007a) Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol 5:115-125.
6. Boison D. (2007b) Adenosine, astrogliosis and seizures: a new perspective of epileptogenesis. Neuron Glia Biol 2:S9.
7. Boison D. (2008) The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol 84:249-262.
8. Boison D. (2009a) Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Epilepsy Res 85:131-141.
9. Boison D. (2009b) Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics 6:278-283.
10. Boison D. (2010a) Inhibitory RNA in epilepsy: research tool and therapeutic perspectives. Epilepsia 51:1659-1668.
11. Boison D. (2010b) Adenosine dysfunction and adenosine kinase in epileptogenesis. Open Neurosci J 4:93-101.
12. Boison D, Stewart K-A. (2009) Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol 78:1428-1437.
13. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, Brandner S, Mohler H. (2002) Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA 99:6985-6990. (Pubitemid 34526244)
14. Boison D, Chen JF, Fredholm BB. (2009) Adenosine signalling and function in glial cells. Cell Death Differ; doi:10.1038/cdd.2009.131.
15. Broekman ML, Comer LA, Hyman BT, Sena-Esteves M. (2006) Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 138:501-510. (Pubitemid 43255560)
16. Cui XA, Singh B, Park J, Gupta RS. (2009) Subcellular localization of adenosine kinase in mammalian cells: the long isoform of AdK is localized in the nucleus. Biochem Biophys Res Commun 388:46-50.
17. Erion MD, Wiesner JB, Rosengren S, Ugarkar BG, Boyer SH, Tsuchiya M. (2000) Therapeutic potential of adenosine kinase inhibitors as analgesic agents. Drug Dev Res 50:S14-S16.
18. Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, Frenguelli B. (2009) Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology 56:429-437.
19. Fedele DE, Gouder N, Güttinger M, Gabernet L, Scheurer L, Rulicke T, Crestani F, Boison D. (2005) Astrogliosis in epilepsy leads to over-expression of adenosine kinase resulting in seizure aggravation. Brain 128:2383-2395. (Pubitemid 41407977)
20. Fellin T, Pascual O, Haydon PG. (2006a) Astrocytes coordinate synaptic networks: balanced excitation and inhibition. Physiology (Bethesda) 21:208-215. (Pubitemid 43801250)
21. Fellin T, Sul JY, D'Ascenzo M, Takano H, Pascual O, Haydon PG. (2006b) Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found Symp 276:208-217; discussion 217-221, 233-207, 275-281.
22. Foti S, Haberman RP, Samulski RJ, McCown TJ. (2007) Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther 14:1534-1536. (Pubitemid 47570712)
23. Franklin KBJ, Paxinos G. (1997) The mouse brain in stereotaxic coordinates. Academic Press, Inc, San Diego.
24. Fredholm BB. (2003) Adenosine receptors as targets for drug development. Drug News Perspect 16:283-289.
25. Gouder N, Scheurer L, Fritschy J-M, Boison D. (2004) Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24:692-701. (Pubitemid 38166495)
26. Gray SJ, Blake BL, Criswell HE, Nicolson SC, Samulski RJ, McCown TJ. (2010) Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther 18:570-578.
27. Haberman R, Criswell H, Snowdy S, Ming Z, Breese G, Samulski R, McCown T. (2002) Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol Ther 6:495-500.
28. Halassa MM, Fellin T, Haydon PG. (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13:54-63. (Pubitemid 46186152)
29. Jacobson KA, Gao ZG. (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247-264. (Pubitemid 43336037)
30. Jarvis MF, Mikusa J, Chu KL, Wismer CT, Honore P, Kowaluk EA, McGaraughty S. (2002) Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats. Pharmacol Biochem Behav 73:573-581. (Pubitemid 34876708)
31. Kaplitt M, Leone P, Freese A, Xiao X, Pfaff D, O'Malley K, During M. (1994) Adeno-associated virus (AAV) vectors yield safe delivery and long-term expression of potentially therapeutic genes in the adult mammalian brain. Abstr Soc Neurosci 20:1465.
32. Klein RL, Meyer EM, Peel AL, Zolotukhin S, Meyers C, Muzyczka N, King MA. (1998) Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol 150:183-194. (Pubitemid 28231949)
33. Kowaluk EA, Jarvis MF. (2000) Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 9:551-564. (Pubitemid 30119693)
34. Lee Y, Messing A, Su M, Brenner M. (2008) GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56:481-493.
35. Li T, Lan JQ, Fredholm BB, Simon RP, Boison D. (2007) Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol 3:353-366.
36. Li T, Lan JQ, Boison D. (2008a) Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice. Neuron Glia Biol 4:91-99.
37. Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D. (2008b) Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest 118:571-582. (Pubitemid 351206547)
38. Loscher W, Gernert M, Heinemann U. (2008) Cell and gene therapies in epilepsy - promising avenues or blind alleys? Trends Neurosci 31:62-73.
39. Martin KR, Klein RL, Quigley HA. (2002) Gene delivery to the eye using adeno-associated viral vectors. Methods 28:267-275. (Pubitemid 35341091)
40. McCown TJ. (2004) The clinical potential of antiepileptic gene therapy. Expert Opin Biol Ther 4:1771-1776.
41. McCown TJ. (2005) Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 5:333-338.
42. McCown TJ. (2006a) Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14:63-68.
43. McCown TJ. (2006b) In vivo seizure suppression by adeno-associated virus (AAV)-mediated expression and constitutive secretion of galanin or NPY. Neuropeptides 40:145.
44. McCown TJ. (2009) Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity. Neurotherapeutics 6:307-311.
45. McGaraughty S, Jarvis MF. (2006) Purinergic control of neuropathic pain. Drug Dev Res 67:376-388. (Pubitemid 44277294)
46. McGaraughty S, Cowart M, Jarvis MF, Berman RF. (2005) Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Top Med Chem 5:43-58. (Pubitemid 40202109)
47. Monopoli A, Conti A, Dionisotti S, Casati C, Camaioni E, Cristalli G, Ongini E. (1994) Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine. Arzneimittelforschung 44:1305-1312.
48. Noe F, Nissinen J, Pitkanen A, Gobbi M, Sperk G, During M, Vezzani A. (2007) Gene therapy in epilepsy: the focus on NPY. Peptides 28:377-383. (Pubitemid 46176246)
49. Noe F, Frasca A, Balducci C, Carli M, Sperk G, Ferraguti F, Pitkanen A, Bland R, Fitzsimons H, During M, Vezzani A. (2009) Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics 6:300-306.
50. Oberheim NA, Tian GF, Han X, Peng W, Takano T, Ransom B, Nedergaard M. (2008) Loss of astrocytic domain organization in the epileptic brain. J Neurosci 28:3264-3276. (Pubitemid 351469330)
51. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, Takano H, Moss SJ, McCarthy K, Haydon PG. (2005) Astrocytic purinergic signaling coordinates synaptic networks. Science 310:113-116. (Pubitemid 41434548)
52. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ. (1997) Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther 4:16-24. (Pubitemid 27073218)
53. Pignataro G, Simon RP, Boison D. (2007) Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab 27:1-5. (Pubitemid 46006578)
54. Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, Wolfe JH, Russek SJ, Brooks-Kayal AR. (2006) Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26:11342-11346. (Pubitemid 44772163)
55. Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D. (2007) Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208:26-37. (Pubitemid 47600151)
56. Riban V, Fitzsimons HL, During MJ. (2009) Gene therapy in epilepsy. Epilepsia 50:24-32.
57. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24:3051-3059. (Pubitemid 38405752)
58. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. (2008) Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322:1551-1555.
59. Studer FE, Fedele DE, Marowsky A, Schwerdel C, Wernli K, Vogt K, Fritschy J-M, Boison D. (2006) Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 142:125-137. (Pubitemid 44353936)
60. Szybala C, Pritchard EM, Wilz A, Kaplan DL, Boison D. (2009) Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol 219:126-135.
61. Tian GF, Azmi H, Takano T, Xu QW, Peng WG, Lin J, Oberheim N, Lou NH, Wang XH, Zielke HR, Kang J, Nedergaard M. (2005) An astrocytic basis of epilepsy. Nat Med 11:973-981. (Pubitemid 41294443)
62. Vajda FJE. (2007) Pharmacotherapy of epilepsy: new armamentarium, new issues. J Clin Neurosci 14:813-823.
63. Vezzani A. (2007) The promise of gene therapy for the treatment of epilepsy. Expert Rev Neurother 7:1685-1692.
64. Vezzani A. (2008) Epileptogenic role of astrocyte dysfunction. Epilepsy Curr 8:46-47.
65. Wieser HG. (2004) ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45:695-714.
66. Wilz A, Pritchard EM, Li T, Lan JQ, Kaplan DL, Boison D. (2008) Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials 29:3609-3616.
67. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973-985. (Pubitemid 29295202)